The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Self-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationProtein folding and misfolding
Dobson, C. M. (2003) · Nature · doi:10.1038/nature02261 · Cited by 4,791
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
The Alzheimer's Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.008 · Cited by 1,525
Self-citationCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1449 · Cited by 1,408
CSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
Self-citationAbraham, C. R., Selkoe, D. J., & Potter, H. (1988) · Cell · doi:10.1016/0092-8674(88)90462-x · Cited by 900
Fagan, A. M., Roe, C. M., Xiong, C., Mintun, M. A., Morris, J. C., & Holtzman, D. M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.noc60123 · Cited by 897
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs
Forman, M. S., Trojanowski, J. Q., & Lee, V. M.-Y. (2004) · Nature Medicine · doi:10.1038/nm1113 · Cited by 715
Self-citationEarly inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study
Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710
Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709
Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”
(1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00022-0 · Cited by 666
THE BIOCHEMISTRY OF PARKINSON'S DISEASE
Cookson, M. R. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133400 · Cited by 664
Diagnosis and treatment of Parkinson disease: molecules to medicine
Savitt, J. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29178 · Cited by 650
Han, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00997.x · Cited by 626
Hensley, K., Maidt, M. L., Yu, Z., Sang, H., Markesbery, W. R., & Floyd, R. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08126.1998 · Cited by 507
Frontotemporal dementia: Clinicopathological correlations
Forman, M. S., Farmer, J., Johnson, J. K., Clark, C. M., Arnold, S. E., Coslett, H. B., Chatterjee, A., Hurtig, H. I., Karlawish, J. H., Rosen, H. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20873 · Cited by 478
Self-citationIncreased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease
Gabbita, S. P., Lovell, M. A., & Markesbery, W. R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052034.x · Cited by 478
Parkinson's--Divergent Causes, Convergent Mechanisms
Greenamyre, J. T., & Hastings, T. G. (2004) · Science · doi:10.1126/science.1098966 · Cited by 451
Tokuda, T., Salem, S. A., Allsop, D., Mizuno, T., Nakagawa, M., Qureshi, M. M., Locascio, J. J., Schlossmacher, M. G., & El-Agnaf, O. M. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.024 · Cited by 425
NEURODEGENERATIVE DISEASES: New Concepts of Pathogenesis and Their Therapeutic Implications
Skovronsky, D. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100113 · Cited by 425
Self-citationZhang, B., Maiti, A., Shively, S., Lakhani, F., McDonald-Jones, G., Bruce, J., Lee, E. B., Xie, S. X., Joyce, S., Li, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406361102 · Cited by 413
Self-citationLicastro, F., Pedrini, S., Caputo, L., Annoni, G., Davis, L. J., Ferri, C., Casadei, V., & Grimaldi, L. M. E. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00226-x · Cited by 400
Clark, C. M., Xie, S., Chittams, J., Ewbank, D., Peskind, E., Galasko, D., Morris, J. C., McKeel, D. W., Farlow, M., Weitlauf, S. L., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1696 · Cited by 357
Self-citationPickhardt, M., Gazova, Z., von Bergen, M., Khlistunova, I., Wang, Y., Hascher, A., Mandelkow, E.-M., Biernat, J., & Mandelkow, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410984200 · Cited by 333
Giasson, B. I., Ischiropoulos, H., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00804-3 · Cited by 279
Self-citationFluctuations of CSF amyloid-β levels: Implications for a diagnostic and therapeutic biomarker
Bateman, R. J., Wen, G., Morris, J. C., & Holtzman, D. M. (2007) · Neurology · doi:10.1212/01.wnl.0000256043.50901.e3 · Cited by 260
Webster, S., Lue, L.-F., Brachova, L., Tenner, A. J., McGeer, P. L., Terai, K., Walker, D. G., Bradt, B., Cooper, N. R., & Rogers, J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00042-0 · Cited by 258
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment
de Leon, M. J., DeSanti, S., Zinkowski, R., Mehta, P. D., Pratico, D., Segal, S., Rusinek, H., Li, J., Tsui, W., Saint Louis, L. A., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.003 · Cited by 253
Self-citationBiological markers for therapeutic trials in Alzheimer’s disease
Frank, R. A., Galasko, D., Hampel, H., Hardy, J., de Leon, M. J., Mehta, P. D., Rogers, J., Siemers, E., & Trojanowski, J. Q. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00002-2 · Cited by 252
Self-citationReduced levels of amyloid β-peptide antibody in Alzheimer disease
Du, Y., Dodel, R., Hampel, H., Buerger, K., Lin, S., Eastwood, B., Bales, K., Gao, F., Moeller, H. –., Oertel, W., et al. (2001) · Neurology · doi:10.1212/wnl.57.5.801 · Cited by 235
The Role of Biomarkers in Clinical Trials for Alzheimer Disease
Thal, L. J., Kantarci, K., Reiman, E. M., Klunk, W. E., Weiner, M. W., Zetterberg, H., Galasko, D., Praticò, D., Griffin, S., Schenk, D., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000191420.61260.a8 · Cited by 232
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer’s disease
Grossman, M., Farmer, J., Leight, S., Work, M., Moore, P., Van Deerlin, V., Pratico, D., Clark, C. M., Coslett, H. B., Chatterjee, A., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20477 · Cited by 228 · cited 1×
“For example, the application of an AD CSF biomarker panel of tau, Aβ1–42 and 8,12-iso-iPF 2α -VI to a cohort of FTD patients and controls suggested that this panel can distinguish FTD from AD because the values for these CSF biomarkers in FTD patients were more similar to controls than to AD patient”
ResultSelf-citationNeurofilament protein in cerebrospinal fluid: A marker of white matter changes
Sjögren, M., Blomberg, M., Jonsson, M., Wahlund, L. ‐., Edman, Å., Lind, K., Rosengren, L., Blennow, K., & Wallin, A. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1242 · Cited by 209
Van Nostrand, W. E., Wagner, S. L., Shankle, W. R., Farrow, J. S., Dick, M., Rozemuller, J. M., Kuiper, M. A., Wolters, E. C., Zimmerman, J., & Cotman, C. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2551 · Cited by 208
Castaño, E. M., Roher, A. E., Esh, C. L., Kokjohn, T. A., & Beach, T. (2006) · Neurological Research · doi:10.1179/016164106x98035 · Cited by 201
Plasma Aβ in Alzheimer's disease—up or down?
Zetterberg, H., & Blennow, K. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70503-8 · Cited by 200
Sennvik, K., Fastbom, J., Blomberg, M., Wahlund, L.-O., Winblad, B., & Benedikz, E. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00929-5 · Cited by 193
The cytoskeleton in neurodegenerative diseases
Cairns, N. J., Lee, V. M., & Trojanowski, J. Q. (2004) · The Journal of Pathology · doi:10.1002/path.1650 · Cited by 192
Self-citationCytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
Sjögren, M., Rosengren, L., Minthon, L., Davidsson, P., Blennow, K., & Wallin, A. (2000) · Neurology · doi:10.1212/wnl.54.10.1960 · Cited by 181
Lanzrein, A.-S., Johnston, C. M., Perry, V. H., Jobst, K. A., King, E. M., & Smith, A. D. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199809000-00016 · Cited by 178
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease
Colciaghi, F., Marcello, E., Borroni, B., Zimmermann, M., Caltagirone, C., Cattabeni, F., Padovani, A., & Di Luca, M. (2004) · Neurology · doi:10.1212/01.wnl.0000106953.49802.9c · Cited by 178
Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease
Zhang, J., Goodlett, D. R., Quinn, J. F., Peskind, E., Kaye, J. A., Zhou, Y., Pan, C., Yi, E., Eng, J., Wang, Q., et al. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7205 · Cited by 176
Tohgi, H., Abe, T., Yamazaki, K., Murata, T., Ishizaki, E., & Isobe, C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00406-1 · Cited by 173
Serum levels of the iron binding protein p97 are elevated in Alzheimer′s disease
Kennard, M. L., Feldman, H., Yamada, T., & Jefferies, W. A. (1996) · Nature Medicine · doi:10.1038/nm1196-1230 · Cited by 169
Hsiung, G.-Y. R. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031789 · Cited by 164
Sheng, J. G., Mrak, R. E., Rovnaghi, C. R., Kozłowska, E., Eldik, L. J. V., & Griffin, W. S. T. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00037-1 · Cited by 157
Lovell, M. A., & Markesbery, W. R. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.392 · Cited by 151
Transgenic animal models of tauopathies
Lee, V. M. ‐., Kenyon, T. K., & Trojanowski, J. Q. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.014 · Cited by 141
Self-citationLuca, M. D., Pastorino, L., Bianchetti, A., Perez, J., Vignolo, L. A., Lenzi, G. L., Trabucchi, M., Cattabeni, F., & Padovani, A. (1998) · Archives of Neurology · doi:10.1001/archneur.55.9.1195 · Cited by 138
Human Kallikrein 6 as a Biomarker of Alzheimer’s Disease
Diamandis, E. P., Yousef, G. M., Petraki, C. D., & Soosaipillai, A. R. (2000) · Clinical Biochemistry · doi:10.1016/s0009-9120(00)00185-5 · Cited by 128
Comparative Proteomic Analysis of Intra- and Interindividual Variation in Human Cerebrospinal Fluid
Hu, Y., Malone, J. P., Fagan, A. M., Townsend, R. R., & Holtzman, D. M. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500207-mcp200 · Cited by 121
Platelet APP isoform ratios correlate with declining cognition in AD
Baskin, F., Rosenberg, R. N., Iyer, L., Hynan, L. S., & Cullum, C. M. (2000) · Neurology · doi:10.1212/wnl.54.10.1907 · Cited by 110
Soluble derivatives of the β amyloid protein precursor in cerebrospinal fluid
Palmert, M. R., Usiak, M., Mayeux, R. P., Raskind, M. A., Tourtellotte, W. W., & Younkin, S. G. (1990) · Neurology · doi:10.1212/wnl.40.7.1028 · Cited by 106
Hu, Y., Shanshu, H., Wang, X., Duan, Q., Khatoon, S., Iqbal, K., Grundke, I., & Wang, J. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00047-2 · Cited by 106
Autoantibodies in Neurodegenerative Diseases: Antigen-Specific Frequencies and Intrathecal Analysis
Terryberry, J. W., Thor, G. T., & Peter, J. B. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00049-9 · Cited by 104
Rice, A., Liu, Y., Michaelis, M. L., Himes, R. H., Georg, G. I., & Audus, K. L. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040114b · Cited by 99
Cholesterol, Aβ and Alzheimer's disease
Hartmann, T. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01990-1 · Cited by 99
Padovani, A., Borroni, B., Colciaghi, F., Pettenati, C., Cottini, E., Agosti, C., Lenzi, G. L., Caltagirone, C., Trabucchi, M., Cattabeni, F., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.1.71 · Cited by 96
α1-Antichymotrypsin and IL-1β are not increased in CSF or serum in Alzheimer's disease
Pirttilä, T., Mehta, P. D., Frey, H., & Wísniewski, H. M. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90026-4 · Cited by 94
Hampel, H. J., Teipel, S. J., Padberg, F., Haslinger, A., Riemenschneider, M., Schwarz, M., Kötter, H. U., Scheloske, M., Buch, K., Stübner, S., et al. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01146-4 · Cited by 93
Michaelis, M. L., Ansar, S., Chen, Y., Reiff, E. R., Seyb, K. I., Himes, R. H., Audus, K. L., & Georg, G. I. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074450 · Cited by 91
Nosology of Parkinson’s Disease: Looking for the Way Out of a Quackmire
Forman, M. S., Lee, V. M. ‐., & Trojanowski, J. Q. (2005) · Neuron · doi:10.1016/j.neuron.2005.07.021 · Cited by 90
Self-citationTumani, H., Shen, G., Peter, J. B., & Brück, W. (1999) · Archives of Neurology · doi:10.1001/archneur.56.10.1241 · Cited by 75
Screening for Inhibitors of Tau Polymerization
Pickhardt, M., von Bergen�, M., Gažová, Z., Hascher, A., Biernat, J., Mandelkow, E., & Mandelkow�, E. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585891 · Cited by 74
Serum Melanotransferrin, p97 as a Biochemical Marker of Alzheimer's Disease
Kim, D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00230-x · Cited by 70
Mecocci, P., Parnetti, L., Romano, G., Scarelli, A., Chionne, F., Cecchetti, R., Polidori, M. C., Palumbo, B., Cherubini, A., & Senin, U. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00180-v · Cited by 69
Glial Fibrillary Acidic Protein in the Cerebrospinal Fluid of Patients with Dementia
Wallin, A., Blennow, K., & Rosengren, L. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106891 · Cited by 69
Ibach, B., Binder, H., Dragon, M., Poljansky, S., Haen, E., Schmitz, E., Koch, H., Putzhammer, A., Kluenemann, H., Wieland, W. F., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.005 · Cited by 67
Dickey, C. A., Eriksen, J. L., Kamal, A., Burrows, F. J., Kasibhatla, S. R., Eckman, C. B., Hutton, M., & Petrucelli, L. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585927 · Cited by 66
Licastro, F., Morini, M. C., Polazzi, E., & Davis, L. J. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00163-i · Cited by 58
Cholesterol, Aβ and Alzheimer's disease
Hartmann, T. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(01)00008-x · Cited by 51
Smyth, M. D., Cribbs, D. H., Tenner, A. J., Shankle, W. R., Dick, M. B., Kesslak, J. P., & Cotman, C. W. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)00055-7 · Cited by 50
Henriksson, T., Barbour, R., Braa, S., Ward, P. J., Fritz, L. C., Johnson‐Wood, K., Chung, H. D., Burke, W. J., Reinikainen, K. J., Riekkinen, P., et al. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02026.x · Cited by 47
Tanaka, J., Nakamura, K., Takeda, M., Tada, K., Suzuki, H., Morita, H., Okado, T., Hariguchi, S., & Nishimura, T. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03926.x · Cited by 45
Xu, S., & Gaskin, F. (1997) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(96)01861-1 · Cited by 40
The Role of Synaptic Proteins in Alzheimer's Disease
Masliah, E. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05562.x · Cited by 39
Zighetti, M. L., Chantarangkul, V., Tripodi, A., Mannucci, P. M., & Cattaneo, M. (2002) · PubMed · Cited by 38
Licastro, F., Pedrini, S., Davis, L. J., Caputo, L., Tagliabue, J., Savorani, G., Cucinotta, D., & Annoni, G. (2001) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200101000-00007 · Cited by 30
Takahashi, M., Stanton, E. B., Moreno, J. I., & Jackowski, G. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.375 · Cited by 15
Serum p97 levels as an aid to identifying Alzheimer's disease
Feldman, H., Gabathuler, R., Kennard, M. L., Nurminen, J., Levy, D., Foti, S., Foti, D. J., Beattie, B. L., & Jefferies, W. A. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3510 · Cited by 15
Clark, C. M., Praticò, D., Shaw, L. M., Leight, S., Xie, S. X., Gu, A. Y., Lee, V. M. ‐., & Trojanowski, J. Q. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.2347 · Cited by 12
Self-citationFillit, H. M., & Refolo, L. M. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585729 · Cited by 10
Webster (1996) · doi:10.1002/(sici)1097-4547(19961001)46:1
Cited by
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationAlzheimer's Disease Neuroimaging Initiative (ADNI)
Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572
Self-citationTau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Self-citationCerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Self-citationMild Cognitive Impairment: Ten Years Later
Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., Smith, G. E., & Jack, C. R. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.266 · Cited by 1,447
Metadata
- Authors
- Shaw, L. M., Korecka, M., Clark, C. M., Lee, V. M.-Y., & Trojanowski, J. Q.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-03-09
- Volume
- 6
- Issue
- 4
- Pages
- 295-303
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2054093987
- Cited by
- 339
- References
- 95
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.